Topical chemotherapy creams, most commonly 5-fluorouracil (5-FU), rarely cause the kind of whole-body sickness people associate with intravenous chemotherapy. The drug is designed to stay in the skin, and studies confirm that very little enters the bloodstream. What chemo cream does cause is an often-intense local skin reaction: redness, peeling, crusting, and soreness at the application site that can last for weeks. That reaction is the treatment working, but it catches many people off guard.
Why So Little Gets Into Your Bloodstream
The fear behind “does chemo cream make you sick” usually comes from knowing that 5-fluorouracil is the same drug used in IV chemotherapy for colon, breast, and other cancers. Delivered through a vein, it circulates everywhere and causes nausea, fatigue, mouth sores, and hair loss. Applied to the skin, the math changes dramatically. A study comparing topical 5-FU formulations found that the drug is minimally absorbed into the systemic circulation, with patients using a lower-concentration cream excreting roughly one-fortieth the amount found in the urine of those using the standard 5% cream.1PubMed. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream Even with the higher-strength cream, the quantity reaching the bloodstream is tiny compared to what an IV dose delivers.
This is why dermatologists prescribe 5-FU cream without the battery of blood tests, anti-nausea medications, and monitoring that accompany systemic chemotherapy. You are treating the skin’s surface layer, not flooding your entire body with a cytotoxic drug. For the vast majority of people, the cream’s effects stay where you put it.
What the Skin Reaction Looks Like
If chemo cream won’t make you feel sick, it will make you look like something is very wrong with your skin. That is by design. The cream targets fast-dividing cells, including both the precancerous lesions it is meant to destroy and some of the healthy skin cells nearby. The treated area goes through a predictable sequence of changes, and understanding that sequence helps people avoid panicking or stopping treatment too early.
In the first few days, you may notice mild redness and a slight tingling or burning sensation. Over the following one to two weeks, the area becomes increasingly red, swollen, and tender. Crusting, scaling, and sometimes open erosions develop. In clinical reports, common side effects include erythema, itching, and flaking or scaling, mostly mild in severity.2PubMed. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses The skin can look raw and feel sore enough that some people need mild pain relief. Depending on the regimen, this peaks around two to four weeks and then begins to heal once you stop applying the cream.
Because the treatment essentially strips away damaged skin and lets healthy skin grow back, the erosion phase can also raise the risk of secondary skin infections if the area is not kept clean.3PubMed Central. Topical 5-Fluorouracil associated skin reaction If you notice increasing warmth, spreading redness beyond the treated zone, pus, or fever, contact your doctor. A simple wound infection is manageable, but letting it progress is not.
When People Actually Do Feel Unwell
While chemo cream overwhelmingly causes only local problems, a small number of people report feeling genuinely sick during treatment. In one published case, a patient using 5-FU cream on her skin noted at a follow-up visit that she had felt unwell during the course, experiencing nausea and general malaise, though she completed treatment as directed.4PubMed Central. Hypogeusia and hyposmia with topical 5-fluorouracil treatment That same patient also temporarily lost her sense of taste and smell, effects typically associated with systemic rather than local drug exposure.
Far more alarming, though exceedingly rare, are cases of severe systemic toxicity. One case report describes a man who, after about a week of applying 5-FU cream, developed extreme fatigue, fever, and mouth erosions. After stopping the cream, his condition worsened: he developed painful mucositis, dehydration, and lost nearly 7 kilograms of body weight, requiring hospitalization.5PubMed Central. Life-Threatening Reaction with Topical 5-Fluorouracil His reaction mimicked the toxicity profile of IV fluorouracil, and genetic testing later revealed the reason.
The DPD Enzyme Factor
The enzyme that breaks down 5-fluorouracil in your body is called dihydropyrimidine dehydrogenase, or DPD. Most people have fully functional copies of the gene that makes this enzyme, so even the small amount of drug that enters the bloodstream from a cream gets cleared quickly. But a small percentage of the population carries gene variants that reduce or eliminate DPD activity. In those people, even topical doses can build up to dangerous levels.
The severe case described above is a textbook DPD deficiency reaction. However, a dedicated study looking specifically at this question found that among patients carrying known DPD gene variants who used topical 5-FU, none developed grade 3 or higher toxicity (the kind requiring hospitalization or causing life-threatening complications). Those with a variant did have a nominally higher rate of mild side effects compared to patients without the variant, but the difference was not statistically significant.6PubMed Central. Risk of Toxicity from Topical 5-Fluorouracil Treatment in Patients Carrying DPYD Variant Alleles
This is reassuring but requires some context. The study looked at the most common DPD variants, and its sample of variant carriers was modest. People with complete DPD deficiency, which is extremely rare, remain at real risk. If you have a family history of severe reactions to fluorouracil-based drugs, or if you have been previously tested and know you carry a DPD variant, mention it to your dermatologist before starting treatment. For the general population, though, the risk of a systemic reaction from chemo cream remains very low.
Imiquimod Is a Different Story
Not all “chemo creams” are 5-FU. Imiquimod (sold under brand names like Aldara and Zyclara) is another topical treatment used for actinic keratoses, superficial skin cancers, and genital warts. It works through a completely different mechanism: rather than directly killing cells, it activates your immune system locally, triggering a flood of inflammatory signaling molecules called cytokines. The resulting inflammation destroys the target lesions, but it can also produce flu-like symptoms that are genuinely systemic.
Patients using imiquimod sometimes report fever, muscle aches, fatigue, and malaise, especially in the first couple of weeks. One study found that although systemic symptoms were infrequent overall, the majority of patients who did develop them noticed the symptoms within about 7 to 11 days of starting a treatment cycle, often preceded by local skin reactions.7JAAD International. Local skin reactions and the onset of influenza-like signs and symptoms induced by imiquimod These symptoms are driven by your immune system’s response, not by the drug circulating through your body the way IV chemo does.
Application site matters here. A case report described a young man who developed recurrent fever, muscle pain, and malaise within hours of each imiquimod application to mucosal tissue on the penis. The researchers attributed this to the highly vascular, non-keratinized nature of that skin, which likely allowed more drug to enter the bloodstream and triggered a stronger immune cascade.8PubMed. Beyond the application site: A case of imiquimod-induced cytokine-mediated systemic symptoms In other words, thin or mucous-membrane skin absorbs more and provokes a bigger response. If you are prescribed imiquimod for a site other than typical sun-damaged skin on the face or scalp, ask your doctor about what to expect.
Factors That Affect How Much Gets Absorbed
Whether you are using 5-FU or imiquimod, a few practical factors influence how much of the drug makes it past the skin’s outer barrier. Skin thickness varies considerably across the body. The face and scalp are relatively thin, and the forearms and hands are thicker. Any disruption to the skin’s integrity, whether from prior procedures, wounds, or the cream’s own erosive effects, can increase absorption.
Research on drug delivery has shown that physically disrupting the skin barrier dramatically increases 5-FU penetration. In one experiment, pretreating skin with microneedles increased the drug’s permeability by about 4.5-fold.9Acta Pharmaceutica Sinica B. The effect of microneedles on the skin permeability and antitumor activity of topical 5-fluorouracil You are not using microneedles at home, but the principle matters: if you apply chemo cream to skin that is already broken, sunburned, or freshly treated with another procedure, you may absorb more than expected. Follow your dermatologist’s guidance on where and when to apply, and avoid covering treated areas with airtight bandages unless specifically told to do so, because occlusion also increases absorption.
The size of the treatment area plays a role too. Treating a single small spot on your nose is very different from covering your entire forehead, scalp, and both forearms. Larger treatment areas mean more surface for the drug to enter the skin, and the cumulative amount that reaches the bloodstream is higher. Some dermatologists use a phased approach for people with extensive sun damage, treating one area at a time rather than everything at once.
Why So Many People Quit Before Finishing
The most common problem with chemo cream is not systemic sickness but the sheer unpleasantness of the local reaction, which leads a surprising number of people to stop treatment early. A systematic review of patient-reported outcomes found that adherence and satisfaction tend to be better with shorter-duration regimens.10PubMed Central. Patient-reported outcomes of topical therapies in actinic keratosis: A systematic review Standard 5-FU protocols often run for two to four weeks of twice-daily application, and by week two, your skin can look alarming enough to erode your willingness to continue.
Frequency matters. A randomized trial comparing daily versus weekly application of 5% 5-FU found that daily use was significantly more effective at clearing actinic keratoses than weekly use.11British Journal of Dermatology. A randomized trial of topical 5% 5‐fluorouracil (Efudix® cream) in the treatment of actinic keratoses comparing daily with weekly treatment That means the uncomfortable daily regimen genuinely works better, and skipping days to manage discomfort likely reduces the cream’s effectiveness. If the reaction is truly intolerable, call your prescribing doctor rather than quietly tapering on your own. They may adjust the schedule, temporarily pause treatment, or switch strategies.
Combination Approaches That Shorten Treatment
One of the more interesting developments in this space combines 5-FU with calcipotriol, a synthetic form of vitamin D typically used for psoriasis. The idea is that calcipotriol ramps up the local immune response against precancerous cells, allowing a much shorter course of 5-FU. A randomized trial tested a four-day regimen of the combination and found striking results: the combination reduced actinic keratoses by roughly 88% on the face, compared to about 26% for 5-FU with a placebo ointment.12JCI Insight. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy
Four days of treatment instead of four weeks is a significant difference for comfort and adherence. A review of this combination approach confirmed that it reduces both local skin reactions and treatment duration compared to 5-FU alone.13PubMed Central. Calcipotriol and 5-Fluorouracil Combination Therapy for the Treatment of Actinic Keratosis in the Clinic: A Review Article The combination is still relatively new in routine clinical practice, but if you are dreading a multi-week 5-FU course, it is worth asking your dermatologist whether this shorter protocol might be appropriate for your situation.
Organ Transplant Recipients and Other Special Populations
People who have received organ transplants take immunosuppressive drugs that dramatically increase their risk of skin cancer and its precursors. These patients often need repeated rounds of topical treatment. A small study of kidney transplant recipients found that 5-FU cream was both effective and safe in this group, with side effects similar to those seen in the general population.2PubMed. The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses A larger systematic review of various topical treatments in transplant recipients noted that no therapy-related transplant rejections or worsening graft function occurred across any of the included trials.14British Journal of Dermatology. Local interventions for actinic keratosis in organ transplant recipients: a systematic review
That is an important reassurance for transplant patients, who understandably worry that provoking an immune response in the skin could somehow trigger a rejection episode. The evidence so far suggests that topical treatments stay local enough to avoid that complication. Still, transplant recipients typically work with both their transplant team and their dermatologist when planning skin cancer prevention, and that coordination is worth maintaining.
Protecting Your Pets
Here is a risk that most patients never think about: 5-fluorouracil is extremely toxic to dogs and cats. A pet that licks a treated area of skin, chews a discarded tube, or even walks across a surface contaminated with residue can become seriously ill. Fatalities in pets have been reported from exposure to very small amounts of the drug.15Baylor University Medical Center Proceedings. Effect of topical dermatologic medications in humans on household pets Dogs are particularly vulnerable.
During treatment, keep tubes stored where pets cannot reach them, cover treated skin if your pet likes to lick you, and wash your hands thoroughly after every application. Dispose of used tissues, cotton pads, or gloves in a sealed container. If you suspect your pet has been exposed, treat it as a veterinary emergency. This is not a hypothetical concern: dermatologists should be flagging it for every patient who has animals at home, and many do not.
Newer Treatments With Less Discomfort
If the local reaction profile of 5-FU still sounds daunting, newer alternatives are entering the picture. Tirbanibulin is a more recently approved topical treatment for actinic keratoses that works through a different mechanism. In a randomized comparative study against 5-FU and photodynamic therapy (another common approach), tirbanibulin showed significantly lower local skin reaction scores than both comparators.16PubMed. Randomized comparative study of 5-Fluorouracil 4%, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses Its treatment course is also short, typically five consecutive days. The tradeoff is that it is newer, more expensive, and long-term comparative data on recurrence are still building.
Photodynamic therapy, which uses a light-sensitizing cream followed by exposure to a specific wavelength of light, is another option that avoids weeks of at-home cream application. It involves an in-office visit and can be painful during the light exposure itself, but the skin reaction peaks quickly and resolves faster than a full 5-FU course. Each treatment has its own set of compromises between effectiveness, side effects, cost, and convenience, and your dermatologist can help match the approach to your specific situation and the extent of your skin damage.
The Emotional Side of Looking Worse Before Looking Better
Something that clinical trials rarely capture well is how people feel about their appearance during chemo cream treatment. Your face or scalp can look raw, inflamed, and crusted for weeks. Research on facial skin toxicities from cancer therapies found that the symptom-and-feelings domain had the highest impact on quality of life among all the categories measured, more than effects on daily activities, work, or personal relationships.17Asia-Pacific Journal of Oncology Nursing. Targeted Therapy-induced Facial Skin Toxicities: Impact on Quality of Life in Cancer Patients Even when the overall quality-of-life impact was rated as small on standard scales, the emotional toll of visible skin changes stood out.
If you are planning a course of 5-FU on your face, scheduling it during a period when you can comfortably stay home or at least minimize social obligations can help. Some people time it around vacations or slow periods at work. Others find that simply knowing what to expect, and that the reaction is temporary and a sign the treatment is working, makes the experience less distressing than going in blind. Take before-and-after photos if you can; seeing the healthy skin that emerges on the other side is a useful motivator when the treatment is at its ugliest midpoint.